Verastem Stock Net Income

VSTM Stock  USD 3.93  0.14  3.69%   
Verastem fundamentals help investors to digest information that contributes to Verastem's financial success or failures. It also enables traders to predict the movement of Verastem Stock. The fundamental analysis module provides a way to measure Verastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verastem stock.
Last ReportedProjected for Next Year
Net Loss-87.4 M-91.7 M
Net Loss-76.8 M-80.6 M
Net Loss-66.4 M-69.8 M
Net Loss(3.96)(4.16)
Net Income Per E B T 1.15  1.18 
As of the 22nd of November 2024, Net Income Per E B T is likely to grow to 1.18, while Net Loss is likely to drop (91.7 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Verastem Company Net Income Analysis

Verastem's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Verastem Net Income

    
  (87.37 M)  
Most of Verastem's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verastem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Verastem Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Verastem is extremely important. It helps to project a fair market value of Verastem Stock properly, considering its historical fundamentals such as Net Income. Since Verastem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Verastem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Verastem's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Verastem Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

15,697.5

At this time, Verastem's Accumulated Other Comprehensive Income is very stable compared to the past year.
Based on the recorded statements, Verastem reported net income of (87.37 Million). This is 125.6% lower than that of the Biotechnology sector and 224.73% lower than that of the Health Care industry. The net income for all United States stocks is 115.3% higher than that of the company.

Verastem Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verastem's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Verastem could also be used in its relative valuation, which is a method of valuing Verastem by comparing valuation metrics of similar companies.
Verastem is currently under evaluation in net income category among its peers.

Verastem Current Valuation Drivers

We derive many important indicators used in calculating different scores of Verastem from analyzing Verastem's financial statements. These drivers represent accounts that assess Verastem's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Verastem's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap99.9M326.6M357.5M77.5M69.7M66.2M
Enterprise Value164.0M281.4M259.5M29.6M34.0M32.3M

Verastem ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Verastem's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Verastem's managers, analysts, and investors.
Environmental
Governance
Social

Verastem Institutional Holders

Institutional Holdings refers to the ownership stake in Verastem that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Verastem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Verastem's value.
Shares
Affinity Asset Advisors, Llc2024-09-30
400 K
State Street Corp2024-06-30
359 K
Morgan Stanley - Brokerage Accounts2024-06-30
332.4 K
Northern Trust Corp2024-09-30
286.6 K
Kennedy Capital Management Inc2024-06-30
212.2 K
Sio Capital Management, Llc2024-06-30
133.4 K
Charles Schwab Investment Management Inc2024-09-30
103.6 K
Ubs O'connor Llc2024-06-30
100.4 K
Susquehanna International Group, Llp2024-06-30
89.9 K
Vanguard Group Inc2024-09-30
1.9 M
Bvf Inc2024-09-30
1.7 M

Verastem Fundamentals

About Verastem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Verastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out Verastem Piotroski F Score and Verastem Altman Z Score analysis.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
0.331
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.37)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.